Abu Dhabi Emirate, United Arab Emirates
I build and invest in frontier technologies across biotech, deeptech, AI, and advanced science. I am the founder of F1 Biosciences, a UAE-based frontier biotech company focused on longevity, genetic preservation, and biological infrastructure. Before that, I spent 10+ years investing in and supporting early-stage technologies across biotech, synthetic biology, future food, deeptech, and applied science. My experience spans the GCC and Southeast Asia, where I have worked with founders, investors, family offices, research institutions, and innovation ecosystems on venture building, fundraising, market entry, and technology commercialization. My strength is translating complex science into fundable, scalable ventures – from evaluating technology and refining business models to building partnerships, investor narratives, and go-to-market strategies. I am based in the UAE and focused on building and supporting the next generation of AI, deeptech, and biotech companies across the GCC and emerging global markets.
Building the biological infrastructure for longevity science at the intersection of genetic preservation, epigenetic reprogramming, and comparative aging biology. F1 Biosciences develops translational longevity platforms using animal models – applying SCNT, cross-species genomics, and cryopreservation across 196+ species to map aging biology before human application. Our team's track record: 1,000+ cloned animals, camel SCNT with confirmed pregnancies, cross-species embryo work including Arabian Tahr, conservation programs for critically endangered GCC fauna. Scientific Advisory Board across Texas A&M · UC Davis · University of Oslo · University of Massachusetts · leading longevity researchers in EU and CIS. Building in the GCC deliberately. The region is constructing biotech infrastructure in real time – and first movers compound.
RNK.VC is focusing on the most innovative solutions in biotech and deeptech field. Our main areas of investment are in cutting-edge biotechnology, including ecology tech, true biotech, foodtech, and deeptech. Our mission is to identify and invest in the most promising startups with a strong potential to transform the industry and become global market leaders.
Skytyx operates at the frontier of genetic science across three verticals: advanced cloning services for animals (in partnership with California Genetics), a genetic biobank for long-term cryopreservation of animal and plant species, and marine biodiversity science. Based in UAE. The cloning infrastructure, cell preservation protocols, and scientific partnerships built through Skytyx giving us capabilities in the lab that most early-stage biotechs spend years trying to build.
ASTER VC (aster-vc.com) began as an investment-focused advisory working with private investors and high-net-worth individuals on venture portfolio construction and technology investments. Over time, the platform evolved into a broader strategic advisory practice, supporting startups, family offices, and investors across fundraising, venture portfolio strategy, and science & technology consulting. Originally active in Hong Kong, ASTER VC now focuses on advisory work across the Gulf region, working with founders and investors in the UAE, Saudi Arabia, and Qatar, with a strong emphasis on deep tech and frontier technologies